38. Fisman D N, Kaye K M. Once-daily dosing of aminoglycoside antibiotics. Inf Dis Clin North Am 2000; 14: 475-87.
39. Barranco Hernández E. Aminoglucósidos. Acta Médica. 2004; 8(1): 48–53.
40. Urrutia Mora O, Fernández Reverón F, Alonso González E, Francisco Pérez JC, Pérez Moure RF y López Hernández J. Comportamiento de la resistencia antibiótica en una Unidad de Cuidados Intensivos Pediátricos. Rev Cub Med Int Emerg2003;2:17-25.
41. Wisplinghoff H, Edmond MB, Pfaller MA, et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States Hospitals: Clinical features, molecular epidemiology and antimicrobial susceptibility. Clin Infec Dis 2000;31: 690-7.
42. Humar A, Ostromecki A, Direnfeld J, Marshall JC, Lazr N, Houston PC, Bolteau P, Conly JM. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infec Dis 2000;31: 1001-7.
43. Serrano N, Gunning K. Interés y aplicación de los scores pronósticos en UCI. En: Manual de Medicina Intensiva. 2da Edición. Madrid. Editorial Harcourt, 2001:614-617.
44. American Thoracic Society. Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
45. Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore). 2007;86:103-11.
46. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133:610-7.
47. Park P, Hugh J, Garton L,Kokan MJ, Thompsom G. Risk of infection with prolonged ventricular catheterization. Neurosurgery 2004;55(3):594.
48. Georges H, Leroy O, Guery B, Alfandary S, Beaucaire G. Predispossing factors for nosocomial pneumonia in patients receiving mechanical ventilation and requiring tracheostomy. Chest 2000;118 :767-74.
49. Shorr AF, Wunderink RG. There is no «cap» on the importanceof community-acquired pneumonia in the ICU. Chest. 2008;133:590-2.
50. Larrondo Muguercia H, Crespo Silva A, León Pérez D, Lozano Valdés D, Herrera Torres ML. Comportamiento epidemiológico de la sepsis en una Unidad de Cuidados Críticos.Ciudad de la Habana. 2002. Disponible en CD: ISBN 959-7164-07-8.
51. Alvarez Lerma F. Vigilancia de la infección nosocomial en pacientes críticos: programa ENVIN. REMI 2004;.4 (8). Artículo16.URL en http://remi.uninet.edu
52. Wisplinghoff H, Edmond MB, Pfaller MA, et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States Hospitals: Clinical features, molecular epidemiology and antimicrobial susceptibility. Clin Infec Dis 2000; 31: 690-7.
53. Humar A, Ostromecki A, Direnfeld J, Marshall JC, Lazr N, Houston PC, Bolteau P, Conly JM. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infec Dis 2000;31: 1001-7.
54. Neuhauser M, Weintein RA, Rydman R, Danziger LH.Antibiotic resistance among gram- negative bacilli inus. intensive care units: implications for fluoroquinoloneuse. JAMA. 2003 ; 289: 885-888.
55. Álvarez Lerma, F., Grau, S., Gracia Arnillas, M.P. Gram-positive cocci infections in intensive care: Guide to antibacterial selection. Drugs 2006; 66: 751-768.
56. Gundian González J, Gassiot Nuño C, Pino Alfonso PP, Ramos Gómez MM, Cid Guedes A, Hernandez Pino Y. Tratamiento de la neumonía nosocomial. Acta Medica 2000;9 (1-2):106-1
57. Appleton A. Bacterial resistance. A world wide problem. Clin Lab Intern 2001;25(4):22-3.
58. Rodrígue Bano J, Cisneros JM, Fernández Cuenca F, Ribera A, Vila J, Pascual A, Martinez Martinez L, Pachon J; Grupo de Estudio de Infección Hospitalaria (GEIH). Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 2004;25 (10):819-24.
59. Abbo A, Navon Venezia S, Hammer Muntz O, Kritchell T, Slegman Igra Y, Carmell Y. Multidrug resistant Acinetobacter baumannii. Emerg Infect Dis 2005;1 (1):22-9.
60. Fridkin S K. Routine cycling of antimicrobial agents as an infection-control measure. Clin Infect Dis 2003; 36: 1438-44.
61. Jesse.B. et al, Libro de Cuidados Intensivos. Vol I, Segunda Edición, ED Mc Graw-Hill Interamericana, México, 37-48,2003.
62. Cordero DM, García AL, Barreal RT, Jiménez J, Rojas N. Comportamiento de la infección nosocomial en las unidades de terapia en un período de 5 años. Rev Cubana Hig Epidemiol 2002;40:79-88.